This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 14 EPO patents, primarily in Amino Acid Production. Top assignee: Ajinomoto Co., Ltd.. Active years: 2004-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2015
Areas of Expertise:
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can write an article about inventor Yury Ivanovich Kozlov for you.
Title: The Inventive Mind of Yury Ivanovich Kozlov
Introduction:
Yury Ivanovich Kozlov, a dedicated inventor based in Moscow, Russia, has made significant contributions to the field of biotechnology with a remarkable total of 22 patents to his name.
Latest Patents:
Kozlov's recent patents showcase his innovative prowess in the realm of bioprocessing and genetic engineering. One of his latest inventions involves enhancing the productivity of purine nucleosides and purine nucleotides using specific bacterial strains. Additionally, he has disclosed a method for producing valuable metabolites from acetyl-coenzyme A by modifying bacterial enzymes.
Career Highlights:
Currently employed at Ajinomoto Co., Ltd., Kozlov continues to push the boundaries of biological research and innovation. His expertise in genetic modification and metabolic engineering has led to groundbreaking developments in the field of biotechnology.
Collaborations:
In his inventive journey, Kozlov has collaborated closely with notable coworkers such as Konstantin Vyacheslavovich Rybak and Ekaterina Aleksandrovna Slivinskaya. Together, they have propelled forward various projects aimed at harnessing the potential of bacterial systems for industrial applications.
Conclusion:
Yury Ivanovich Kozlov's inventive spirit and dedication to scientific advancement have solidified his reputation as a pioneering figure in the realm of biotechnology. His numerous patents and collaborative efforts underscore his commitment to driving innovation and shaping the future of bioprocessing technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
